The Commercial Reality of Gene Therapy Approval

Rocket Pharma secured FDA approval for Kresladi, a gene therapy for a childhood disorder. Despite the scientific win, the stock fell as investors weighed commercialization challenges like slow rollout and reimbursement, highlighting the importance of execution in biotech trading.

Listen